Key facts
- This page summarizes Dwain K. Morris-Irvin's Form 4 filing for NovAccess Global Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Mar 2022, 10:09.
Dwain K. Morris-Irvin - 14 Mar 2022 Form 4 Insider Report for NovAccess Global Inc.
- Reporting relationship
- Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 14 Mar 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ Dwain K. Morris-Irvin
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Dwain K. Morris-Irvin filed Form 4 for NovAccess Global Inc. on 14 Mar 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XSNX
transaction
Series B Preferred Stock, $0.01 par value per share
Other
- Transaction value
- Shares
- +600
- Change %
- Price
- Shares after
- 600
- Date
- 14 Mar 2022
- Ownership
- By Irvin Consulting, LLC
- Footnotes
- F1
XSNX
holding
Common Stock, no par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,800,000
- Date
- 14 Mar 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XSNX
transaction
Derivative
Series B Preferred Stock, $0.01 par value
Other
- Transaction value
- Shares
- +600
- Change %
- Price
- Shares after
- 600
- Date
- 14 Mar 2022
- Ownership
- By Irvin Consulting, LLC,
- Underlying class
- Common Stock, no par value
- Underlying amount
- 6,000,000
- Exercise price
- $0.000000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Effective March 14, 2022, Irvin Consulting, LLC, a California limited liability company owned and controlled by to Dr. Irvin, purchased in a private transaction 600 shares of Series B preferred stock from TN3, LLC. Irving Consulting paid a total of $7,223 for the preferred shares.
Footnote F2
Each share of Series B preferred stock is currently convertible at the option of the holder into 10,000 shares of common stock and entitles the holder to cast 40,000 votes on any action presented to shareholders. The preferred stock conversion feature has no expiration date.